Ginkgo Bioworks Holdings, Inc. (DNA) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Ginkgo Bioworks Holdings, Inc. (DNA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $561.1M, listed on NYSE, employing roughly 834 people, carrying a beta of 1.78 to the broader market. Ginkgo Bioworks Holdings, Inc. Led by Jason Kelly, public since 2021-04-19.
Snapshot as of May 15, 2026.
- Spot Price
- $7.70
- Total OI
- 19.5K